DJIA 17,195.42 221.11 1.30%
NASDAQ 4,566.14 16.91 0.37%
S&P 500 1,994.65 12.35 0.62%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

110.85 0.94 (0.86%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $110.85 0.86%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $109.21
Previous Close $109.91
Daily Range $108.61 - $111.82
52-Week Range $58.06 - $116.88
Market Cap $26.4B
P/E Ratio -33.71
Dividend (Yield) $0.00 (0.0%)
Volume 1,398,346
Average Daily Volume 2,122,759
Current FY EPS -$2.70

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

Why You Shouldn't Worry About Gilead Sciences, Inc.

Gilead's Sovaldi sales tumbled 20% in Q3, but that shouldn't concern investors.

Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog

Nasdaq 100 Movers: FB, WDC

Vertex Pharmaceuticals (VRTX) Earnings Report: Q3 2014 Conference Call Transcript

Vertex Pharmaceuticals Incorporated's (VRTX) CEO Jeffrey Leiden on Q3 2014 Results - Earnings Call T

Vertex Pharmaceuticals Incorporated's (VRTX) CEO Jeffrey Leiden on Q3 2014 Results - Earnings Call Transcript

Vertex Pharmaceuticals Incorporated Plays the Earnings Waiting Game

Year-over-year growth of 25% is impressive but pales in comparison with Vertex's potential.

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2014 Results - Earnings Call Webcast

Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog

Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog

Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? - Analyst Blog

The 5 Most Expensive Drugs in the World

The five most expensive drugs in the world from 2013 will set you back a minimum of $205,000 per year. Find out what makes these drugs so special -- and why they carry such exorbitant price tags.

See More VRTX News...

VRTX's Top Competitors

VRTX $110.85 (0.86%)
Current stock: VRTX
AMGN $161.58 (1.70%)
Current stock: AMGN
GILD $114.22 (3.16%)
Current stock: GILD
BIIB $321.00 (1.89%)
Current stock: BIIB